Golvatinib (E7050)

Post Date:
Apr 03,2015
Expiry Date:
Apr 02,2016
Detailed Description:
Cas No. :928037-13-2 Quantity: 50g
Specs:98% purity
Payment Method: T/T, Western Union
Golvatinib (E7050) is an orally bioavailable dual kinase inhibitor of c-Met (hepatocyte growth factor receptor) and VEGFR-2 (vascular endothelial growth factor receptor-2) tyrosine kinases with potential antineoplastic activity. c-Met/VEGFR kinase inhibitor E7050 binds to and inhibits the activities of both c-Met and VEGFR-2, which may inhibit tumor cell growth and survival of tumor cells that overexpress these receptor tyrosine kinases. c-Met and VEGFR-2 are upregulated in a variety of tumor cell types and play important roles in tumor cell growth, migration and angiogenesis.
CAS Registry Number:
928037-13-2

Offter to Sell